Herbal/hormonal dietary supplement possibly associated with prostate cancer progression

Clinical Cancer Research

Volumn 14, Issue 2, 2008, Pages 607-611

  Shariat, Shahrokh F ^a,b   Lamb, Dolores J ^b   Iyengar, Radha G ^a   Roehrborn, Claus G ^a   Slawin, Kevin M ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; BICALUTAMIDE; FOLLITROPIN; GOSERELIN; HERBACEOUS AGENT; HORMONE; LEUPRORELIN; LUTEINIZING HORMONE; TESTOSTERONE;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CAPILLARY ELECTROCHROMATOGRAPHY; CASE REPORT; CELL STRAIN LNCAP; DIET SUPPLEMENTATION; FOLLITROPIN BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; LUTEINIZING HORMONE BLOOD LEVEL; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; TESTOSTERONE BLOOD LEVEL;

AGED; ANDROGENS; CELL LINE, TUMOR; DIETARY SUPPLEMENTS; DISEASE PROGRESSION; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TESTOSTERONE;

EID: 38949166047     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-1576     Document Type: Article

References (19)

1. Kurtzweil P. An FDA guide to dietary supplements. FDA Consum 1998;32:28-35.
2. Herbal Rx: The promise and pitfalls. Consum Rep 1999;52:44-8.
3. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998;280:1569-75.
4. Tindle HA, Davis RB, Phillips RS, Eisenberg DM. Trends in use of complementary and alternative medicine by US adults: 1997-2002. Altern Ther Health Med 2005;11:42-9.
5. Matsumoto AM, Gross KM, Sheckter CB, Bremner WJ. The luteinizing hormone-releasing hormone pulse generator in men: abnormalities and clinical management. Am J Obstet Gynecol 1990;163:1743-52.
6. Matsumoto AM, Bremner WJ. Modulation of pulsatile gonadotropin secretion by testosterone in man. J Clin Endocrinol Metab 1984;58:609-14.
7. Sheckter CB, Matsumoto AM, Bremner WJ. Testosterone administration inhibits gonadotropin secretion by an effect directly on the human pituitary. J Clin Endocrinol Metab 1989;68:397-401.
8. Kellis JT, Jr., Vickery LE. Inhibition of human estrogen synthetase (aromatase) by flavones. Science 1984;225:1032-4.
9. Jeong HJ, Shin YG, Kim IH, Pezzuto JM. Inhibition of aromatase activity by flavonoids. Arch Pharm Res 1999;22:309-12.
10. Syrotuik DG, MacFadyen KL, Harber VJ, Bell GJ. Effect of elk velvet antler supplementation on the hormonal response to acute and chronic exercise in male and female rowers. Int J Sport Nutr Exerc Metab 2005;15:366-85.
11. Taplin ME, Balk SP. Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence. J Cell Biochem 2004;91:483-90.
12. Heinlein CA, Chang C. Androgen receptor in prostate cancer. Endocr Rev 2004;25:276-308.
13. Li R, Wheeler T, Dai H, Frolov A, Thompson T, Ayala G. High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy. Am J Surg Pathol 2004;28:928-34.
14. Javidan J, Deitch AD, Shi XB, de Vere White RW. The androgen receptor and mechanisms for androgen independence in prostate cancer. Cancer Invest 2005;23:520-8.
15. Lamb DJ, Puxeddu E, Malik N, et al. Molecular analysis of the androgen receptor in ten prostate cancer specimens obtained before and after androgen ablation. J Androl 2003;24:215-25.
16. Nortier JL, Martinez MC, Schmeiser HH, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 2000;342:1686-92.
17. Curran MJ, Bihrle W III. Dramatic rise in prostate-specific antigen after androgen replacement in a hypogonadal man with occult adenocarcinoma of the prostate. Urology 1999;53:423-4.
18. Loughlin KR, Richie JP. Prostate cancer after exogenous testosterone treatment for impotence. J Urol 1997;157:1845.
19. Gaylis FD, Lin DW, Ignatoff JM, Amling CL, Tutrone RF, Cosgrove DJ. Prostate cancer in men using testosterone supplementation. J Urol 2005;174:534-8; discussion 8.